feed,title,long_url,short_url
Benzinga,Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual Meeting,https://www.benzinga.com/pressreleases/20/12/g18663674/autolus-therapeutics-presents-compelling-auto1-data-from-allcar-phase-1-study-in-adult-acute-lymph,https://j.mp/39RlomR
